Mandate

Vinge has advised Great Security and Garda Group in connection with the acquisition of Comdate Norrlarm

Vinge has advised Great Security, one of Sweden’s largest security companies, in connection with the acquisition of Comdate Norrlarm, the largest independent alarm and security company in northern Sweden. The acquisition strengthens Great Security’s presence in the region and provides direct access to this geographical market.

Comdate Norrlarm is a leading operator in the alarm and security industry and offers advanced security solutions in the areas of burglar alarms, fire alarms, camera surveillance and access control systems.

Great Security is part of Garda Group, one of the largest providers of physical security in Northern Europe. Garda Group consists of security companies in Sweden, Denmark, Norway, Finland, and Germany. Together, the companies have approximately 2,100 employees and an annual turnover of over 5 billion SEK.

Vinge’s team consisted of among other Carl Sander, Linus Adolfsson and Sara Hammond (M&A), Simon Söderholm and Gulestan Ali (Employment), Carla Håkansson, Elis Allmark and Nicklas Thorgerzon (Commercial Contracts, IT and GDPR), Johan Gavelin and Siri Blomberg (IP), Kristoffer Sällfors (Public procurement), Dagne Sabockis and Martin Hammarskiöld (FDI) and Cecilia Loctander (Transaction Support).

Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025